ARID1A and neoplasm: ARID1A is described as an epigenetic tumor suppressor, a component of the so-called SWI/SNF chromatin remodeling complexes, and very frequently- inactivating mutations of this gene are present in more than 50% of ovarian clear cell carcinomas, and approximately 30% of ovarian endometrioid carcinomas [5, 6].